Implantable Cardioverter Defibrillator Therapy in Patients with Cardiac Sarcoidosis
Joseph L. Schuller(University of Michigan), William H. Sauer(Brigham and Women's Hospital), Amit R. Patel(University of Virginia), John F. Beshai(MACOM (United States)), Thomas Crawford(University of Michigan), Duy T. Nguyen(Stanford University), Frank Bogun(University of Michigan), Nadera Sweiss(University of Illinois Chicago), Paul D. Varosy(Rocky Mountain MS Center), Ryan G. Aleong(University of Michigan), Howard D. Weinberger(University of Michigan), Matthew M. Zipse(University of Michigan)
Cited by 151
Related Papers
The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.
|PubMed|2014|505
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias
|EP Europace|2019|461
Multicenter Outcomes for Catheter Ablation of Idiopathic Premature Ventricular Complexes
|JACC. Clinical electrophysiology|2015|382